“…Furthermore, Gse-1 was recognized as a target of miR-489-5p, which was proven to be diminished in breast cancer cells (Chai et al 2016). A case report, which included Gse-1, was published in the year 2013 that found a small de novo duplication (16p24.1) in one patient with a striking clinical phenotype with spastic paraplegia, severe epilepsy, mental retardation, arachnodactyly, malar hypoplasia and an arched palate (Quéméner-Redon et al 2013). In the year 2012, data were published that emphazised the association between the risk of colorectal cancer and variant alleles of KIAA0182, which are part of a single-nucleotide polymorphisms within 3'-untranslated genetic areas (Landi et al 2012).…”